Fosun Pharma repurchases 461,500 shares on Shanghai Exchange

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced today that it repurchased 461,500 of its own ordinary shares on the Shanghai Stock Exchange. The shares were repurchased at a price range of RMB 25.9 to RMB 26.06 per share. The total consideration paid for the repurchased shares was RMB 11,998,110. Following the repurchase, the company's issued shares (excluding treasury shares) is 2,104,238,773, with 14,250,052 shares held as treasury shares. The share repurchase was in accordance with domestic rules, and the company confirmed adherence to moratorium periods regarding further issuance or transfer of shares.